FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular, to gynecology, and is intended for differential diagnostics of cervical intraepithelial neoplasias associated with human papilloma virus of high oncogenic risk. The amount of cells with the CD3+CD4+PD1+TIM3+ and CD3+CD4+PD1+LAG3+ phenotype in the general population of CD3+CD4+ T-lymphocytes is determined in an immunological study. If the amount of cells with said phenotype in each of the variants is less than 2% of the total population of CD3+CD4+ T-lymphocytes, I degree cervical intraepithelial neoplasia is diagnosed. If the amount of cells with said phenotype in each of the variants is 2 to 5% in the total population of CD3+CD4+ T-lymphocytes, II degree cervical intraepithelial neoplasia is diagnosed. If the amount of cells with said phenotype in each of said cases is greater than 5%, III degree cervical intraepithelial neoplasia is diagnosed.
EFFECT: invention ensures determination and differentiation of the degree of development of cervical intraepithelial neoplasia and a reduction in the duration of stay of patients in the in-patient facility.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF GRADE III AND MICROINVASIVE CERVICAL CANCER ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2019 |
|
RU2735660C1 |
| METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF III DEGREE AND PRE-INVASIVE CERVICAL CANCER, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2012 |
|
RU2506892C1 |
| DIAGNOSTIC TECHNIQUE OF CERVICAL INTRAEPITHELIAL NEOPLASIA | 2019 |
|
RU2705816C1 |
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF CERVICAL DYSPLASIA | 2019 |
|
RU2704966C1 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF RECURRENT CERVICAL INTRAEPITHELIAL NEOPLASIAS OF LOW DEGREE OF ONCOGENIC RISK ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION | 2020 |
|
RU2748719C1 |
| METHOD FOR PREDICTING PRE-CANCER DISEASES OF UTERINE CERVIX IN WOMEN WITH PAPILLOMA-VIRAL INFECTION | 2006 |
|
RU2310197C1 |
| METHOD OF CHOOSING TACTICS OF MANAGING PATIENTS WITH CERVICAL NEOPLASIA | 2011 |
|
RU2472424C1 |
| METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
| METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 |
|
RU2660360C2 |
